In a syngeneic mouse melanoma model (using the B16F10 cell line), BAFF upregulates CD40 and PD-L1 expression on B cells and increases CD4+ T cell activation, which acquires both a memory phenotype and Th1 polarization, leading to enhanced anti-tumor immunity (Figure 3) [206]. Here, TNFSF13B is linked to neoplasm.